GlassScriptPhysician profile
Joshua Bloom
NPI 1619408416
$5,964.70
in general payments reported to CMS, 2019-2025
25 companies · $1,098 in 2025
The $1,098 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $34.61 · 2021: $2,820 · 2022: $678 · 2023: $456 · 2024: $297 · 2025: $1,098.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $2,602.20 | 2021 | |
| Davol INC. | $422.89 | 2025 | Phasix Mesh |
| Dilon Technologies, INC. | $406.88 | 2024-2025 | Hemoblast Bellows |
| Kci USA, INC. | $344.51 | 2019-2022 | |
| Stryker Corporation | $267.48 | 2025 | 1788 |
| Integra Lifesciences Corporation | $228.80 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Activ Surgical, INC. | $200.00 | 2022 | |
| Kerecis Limited | $198.84 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tela Bio, INC. | $174.67 | 2022 | |
| Lifenet Health | $152.90 | 2023 | |
| Genentech USA, INC. | $138.75 | 2019 | |
| Becton, Dickinson and Company | $127.53 | 2024 | Phasix Mesh |
| Motiva USA, LLC | $125.00 | 2025 | |
| Ethicon US, LLC | $122.41 | 2022-2023 | Echelon; Endopath, Ethicon, Enseal |
| Medical Device Business Services, INC. | $106.86 | 2019-2025 | Matrixcombo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $74.59 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $44.05 | 2019 | |
| Tei Biosciences INC | $39.04 | 2019 | |
| Puma Biotechnology, INC. | $36.87 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.97 | 2022 | |
| Smith+Nephew, INC. | $21.01 | 2021 | |
| Polynovo North America LLC | $20.34 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.38 | 2019 | |
| Misonix INC | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.